 
                        | Product NDC: | 0781-7106 | 
| Proprietary Name: | Ciclopirox | 
| Non Proprietary Name: | Ciclopirox | 
| Active Ingredient(s): | 80 mg/g & nbsp; Ciclopirox | 
| Administration Route(s): | TOPICAL | 
| Dosage Form(s): | SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0781-7106 | 
| Labeler Name: | Sandoz | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA077687 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20070918 | 
| Package NDC: | 0781-7106-60 | 
| Package Description: | 5.9136 g in 1 BOTTLE, WITH APPLICATOR (0781-7106-60) | 
| NDC Code | 0781-7106-60 | 
| Proprietary Name | Ciclopirox | 
| Package Description | 5.9136 g in 1 BOTTLE, WITH APPLICATOR (0781-7106-60) | 
| Product NDC | 0781-7106 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Ciclopirox | 
| Dosage Form Name | SOLUTION | 
| Route Name | TOPICAL | 
| Start Marketing Date | 20070918 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Sandoz | 
| Substance Name | CICLOPIROX | 
| Strength Number | 80 | 
| Strength Unit | mg/g | 
| Pharmaceutical Classes | Decreased DNA Replication [PE],Decreased Protein Synthesis [PE],Decreased RNA Replication [PE],Protein Synthesis Inhibitors [MoA] |